Washington State House of Representatives Office of Program Research |
BILL ANALYSIS |
Health Care Committee | |
SSB 5390
Brief Description: Concerning improving the quality of care in state-purchased health care programs.
Sponsors: Senate Committee on Health & Long-Term Care (originally sponsored by Senators Keiser, Parlette, Franklin, Kastama, Johnson, Shin, Kohl-Welles and Kline).
Brief Summary of Substitute Bill |
|
|
|
Hearing Date: 3/24/05
Staff: Molly Belozer (786-7104).
Background:
In 2003, legislation was adopted that requires the Health Care Authority (Authority) to
coordinate state agency efforts to adopt uniform policies based on the best available scientific
and medical evidence. Uniform policies across state purchased health care programs were
deemed necessary by the legislation to ensure prudent, cost-effective health services purchasing,
maximize efficiencies in administration of state purchased health care programs, and reduce
administrative burdens on health care providers participating in state purchased health care
programs. Adopted uniform policies are required to address:
1. formal assessment methods, including health technology assessment;
2. monitoring of health outcomes, adverse events, quality, and cost-effectiveness of health services;
3. development of a common definition of medical necessity; and
4. exploration of common strategies for disease management and demand management
programs.
"Best available scientific and medical evidence" is defined in statute as the best available external
clinical evidence derived from systematic research.
Summary of Bill:
The Authority, the Administrator of the Authority, and the Secretary of the Department of Social
and Health Services must work in collaboration with other state agencies that administer state
purchased health care programs, private health care purchasers, health care providers, and health
insurance carriers to use evidence-based medicine principles to develop, in collaboration with
providers, common performance measures. The collaboration must also implement financial
incentives in contracts with insuring entities and providers. The incentives must:
1. reward improvements in health outcomes for individuals with chronic diseases, increased utilization of appropriate preventive health services, and reductions in medical errors; and
2. increase, through appropriate incentives to insuring entities and providers, the adoption
and use of information technology contributing to improved health outcomes, better
coordination of care, and decreased medical errors.
The Authority may require that insuring entities provide subscriber or member demographic and
claims data necessary to implement performance measures or financial incentives related to
performance.
The duty of the Authority to appoint a technical advisory committee relating to health care policy
is removed.
Appropriation: None.
Fiscal Note: Available.
Effective Date: The bill takes effect 90 days after adjournment of session in which bill is passed.